1. European Urology Oncology
Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition 
Jie M. Lam, Wing K. Liu, Thomas Powles, Yen Zhi Tang, Bernadett Szabados 
European Urology Oncology 
DOI: /j.euo
Copyright © 2019 European Association of Urology Terms and Conditions

2. Fig. 1
(A) Best target lesion change from baseline according to Response Evaluation Criteria in Solid Tumours v.1.1 among patients treated with chemotherapy (CT) after an immune checkpoint inhibitor (ICI; n=29). * Subjects who died because of rapid disease progression before imaging following induction of CT after ICI. (B) Duration of response among responders to CT after ICI in both cohorts (n=10). (C) Kaplan-Meier plot of progression-free survival (PFS) time from induction of CT following progression on ICI.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2019 European Association of Urology Terms and Conditions